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ABSTRAK
Pendarahan sel darah bayi jenis rhesus (Rh) positif ke dalam aliran darah ibu 
berdarah Rh negatif boleh berlaku semasa mengandung dan semasa proses 
kelahiran.Perbezaan jenis darah ini menyebabkan ibu menghasilkan Rh 
antibody dan menyebabkan pemusnahan sel pramatang pada darah bayi. Ujian 
Kleihauer adalah kaedah biasa digunakan untuk mengukur pendarah sel darah 
bayi. Walaubagaimanapun tiada penyelarasan khusus antara makmal bagi ujian 
ini dan keputusannya kurang tepat. Teknik sitometri aliran adalah kaedah baru 
menggunakan anti HbF monoclonal. Ia boleh mengkaji lebih banyak sel, lebih 
sensitif dan tepat. Tujuan kajian ini adalah untuk mengukur pendarahan sel darah 
bayi di dalam aliran darah ibu menggunakan dua teknik tersebut dan menentukan 
tahap korelasi antara keduanya. 98 sampel darah ibu mengandung lebih dari 20 
minggu dan selepas bersalin telah dianalisa. Kajian mendapati tahap korelasi yang 
sederhana antara dua kaedah ujian, r = 0.655 (p<0.05) dan tahap keharmonian 
adalah 66.3%. Walau bagaimanapun, kaedah sitometri aliran member bacaan 
yang lebih tinggi untuk 70.4% kes berbanding kaedah Kleihauer. Pemerhatian ini 
mungkin disebabkan oleh cahaya otoflores yang dihasilkan oleh kontaminasi sel 
darah putih atau penggunaan anti HbF yang kurang spesifik berbanding anti-D 
monoclonal. Ia boleh juga berpunca dari jenis fluorokrom yang digunakan. Oleh 
itu, untuk meningkatkan ketepatan keputusan ujian, analisan dua label glycophorin 
A yang spesifik untuk sel darah merah dan perbandingan antara anti HbF dan 
anti-D adalah disyorkan.
Kata kunci: pendarahan sel darah bayi, Kleihauer test, sitometri aliran, anti HbF 
ABSTRACT
Fetomaternal haemorrhage (FMH) may occur following a sensitizing event, during 
pregnancy or at delivery. In cases of rhesus (Rh) incompatibility between mother 
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immunoglobulin for Rh prophylaxis 
(National Blood Transfusion Services, 
Immunoglobulin Working Party, 
1991) stated that at least 500 IU of 
anti-D must be given to every RhD-
negative woman with no preformed 
anti-D within 72hrs of delivery of an 
RhD-positive infant. This dose will 
be sufficient to prevent sensitization 
from a 4ml foetal red blood cell 
bleed (BCSH Blood Transfusion and 
General Haematology Task Force 
1999). Statistics have shown that 0.4% 
of women have a FMH of greater than 
4 ml and up to 0.3% greater than 
15 ml thus will not be protected by 
the standard 500 IU dose of anti-D 
(BCSH Blood Transfusion and General 
Haematology Task Force 2011; Bayliss 
et al. 1991). It is therefore important 
and the fetus, it can thus subject to the haemolytic disease of the newborn. The 
Kleihauer test for quantification of FMH lacks standardization and results are less 
accurate. Furthermore, it cannot differentiate the foetal cell from the adult HbF. 
Flowcytometry analysis using monoclonal antibodies, is a new technique for the 
quantification of FMH and it allows larger number of cells to be analysed. It is also 
able to differentiate the foetal cell from maternal HbF, and thus is more sensitive 
and accurate. The objective of our study was to determine the FMH using the 
flowcytometric analysis of anti-HbF antibody and to correlate the FMH using flow 
cytometry and the standard Kleihauer test. Ninety eight peripheral blood samples 
from pregnant women at more than 20 weeks of pregnancy and post delivery were 
analyzed by both methods. The percentage of the foetal cells were recorded and 
the FMH were calculated. We found a fair correlation between the two methods 
with the correlation coefficient r = 0.633 (p<0.05). The concordance rate was 
66.3%. Flow cytometric method, however, gave higher values in 70.4% of cases 
as compared to the Kleihauer test. These could be due to the autofluoresce of 
contaminated white blood cell or using anti HbF which is less specific than anti-D. 
Other possible factors could be due to the fluorochrome used. Therefore, in order 
to increase the accuracy, we recommend the use of dual labeling of red cells with 
glycophorin A which is a marker for red cells and compare the use of monoclonal 
anti HbF and anti-D for analysis.
Keywords: foetomaternal haemorrhage, Kleihauer test, flow cytometry, anti HbF
INTRODUCTION
FOETOMATERNAL 
HAEMORRHAGE AND THE USE 
OF ANTI-D
Foetomaternal haemorrhage (FMH) 
may occur following a sensitizing event 
during pregnancy or at delivery and 
can lead to RhD immunization. If this 
occurs in a RhD-negative moman with 
a RhD-positive infant, there is a risk 
of HDN and can be fatal (Augustson 
et al. 2006). Assessment of FMH is an 
important element in determining the 
amount of anti-D to be administered 
to a RhD-negative mother following a 
sensitizing event or after delivery of an 
RhD-positive infant.
 The guidelines for the use of anti-D 
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that the volume of any foetomaternal 
bleed is accurately estimated so that 
if necessary a supplementary dose 
of anti-D can be administered and 
maternal alloimmunization prevented. 
 Despite the policy, 1-2% of RhD-
negative pregnant women at risk 
still become sensitize (BCSH Blood 
Transfusion and General Haematology 
Task Force 1999). A Kleihauer 
screening test is usually performed in 
all cases to detect the 1% of women 
who have a bleed larger than 4ml. 
In these cases the Kleihauer test is 
used to quantify the haemorrhage 
and determine the additional dose 
of anti-D immunoglobulin. Cases 
with large bleeds are monitored for 
the disappearance of haemoglobin F 
containing cells using the Kleihauer 
test and for the presence of free anti-D 
in maternal serum.
 Despite earlier publications 
describing methods for assessing 
foetomaternal haemorrhage (Duguid 
& Bromilow 1999) it is recognized 
that there is little standardization of 
techniques (BCSH Blood Transfusion 
and General Haematology Task 
Force 1999; Johnson et al. 1993), a 
fact which can lead to inaccuracies 
in determining the size of any 
foetomaternal haemorrhage.
 The Kleihauer acid elution test is 
the standard method for the detection 
and quantitation of foetomaternal 
haemorrhage in the UK. This test 
identifies foetal cells in the maternal 
circulation by the relative resistance 
of cells containing haemoglobin F to 
acid elution (Kleihauer et al. 1957). 
While the Kleihauer test is sensitive, its 
accuracy in quantifying FMH is open to 
question because of increased method 
and operator variability, low level 
of reproducibility, poor preparation 
technique and lack of standardization 
between laboratories and individuals.
 Numerous sources of error includes 
variations in the thickness of blood 
films, the number of red cells in a low 
power microscope field, the fact that 
some foetal cells do not stain, and 
the difficulty of classifying cells of 
intermediate staining. 
 Furthermore, the Kleihauer test is 
unable to differentiate between foetal 
red cells and adult haemoglobin F 
containing cells which may lead to false 
positive diagnoses due to increased 
levels of maternal HbF cells as a result 
of physiological variations during 
pregnancy (25% in second trimester) 
or traits such as thalassaemia, sickle 
cell anaemia or hereditary persistence 
of foetal Hb (HPFH) (Duckett & 
Constantine 1997; Corsetti et al. 
1987). Descriptions of the Kleihauer 
test method vary between sources 
and therefore it is not surprising that 
wide variations between laboratories 
occur. In view of the problems with 
Kleihauer test, a new technology using 
flow cytometer for detection of HbF 
has been introduced.
 Flow cytometry technique uses 
monoclonal or polyclonal antibodies 
to HbF, either directly conjugated 
with a fluorochrome or used with a 
secondary conjugated antibody to 
identify foetal cells in the maternal 
circulation (Davis et al. 1998; Brown 
& Wittwer 2000). The red cells are 
fixed and permeabilized to allow the 
antibody access to the haemoglobin 
in the cytosol, and the intensity of the 
115
Fetomaternal Haemorrhage by Flowcytometry Med & Health 2015; 10(2): 112-122
staining of the celIs distinguishes foetal 
cells from adult ‘F’ cells. It allows large 
numbers of cells e.g. 50 000 - 100 000 
to be readily counted. The test should 
then be more sensitive and accurate; 
and produce objective, quantitative 
results. However, flow cytometers 
are expensive and generally available 
only in major centers and require staff 
with specific expertise to operate the 
analyzer. 
 While the Kleihauer test is a simple, 
sensitive and cost effective technique 
for detecting patients with a FMH 
below 4 ml, flow cytometry offers 
several advantages in patients with 
larger FMH; 50 000 – 100 000 cells 
are assessed individually using the 
flow cytometer and several sources of 
inherent errors in the Kleihauer test are 
eliminated (Bromilow & Duguid 1997; 
Duckett & Constantine 1997; Corsetti 
et al. 1987). Raised maternal HbF 
concentrations render the Kleihauer 
test inconclusive, whereas the flow 
cytometer is able to distinguish foetal 
cells from adult cells. Furthermore, 
it can detect potentially immunising 
foetal cells even in cases where the Rh 
status of the fetus is not known. This 
method can be used to test mothers 
of any blood group and is not Rhesus 
dependent (Mollison 1972; Johnson et 
al. 1993; Nance et al. 1989).
 The main objectives of the present 
study were to determine the FMH 
using the flow cytometric analysis of 
anti-HbF antibody and to correlate 
the FMH using flow cytometric with 




This was a comparative study to 
measure FMH in pregnant women 
using flow cytometry in comparison 
with conventional Kleihauer test. The 
study was performed using fresh whole 
blood collected in EDTA container 
from pregnant women attended the 
O&G clinic or admitted in UKMMC 
between 2005-2006 with prior consent 
from respective patients before samples 
were withdrawn. All the samples were 
run in the flow cytometry laboratory, 
Blood Bank Unit, Universiti Kebangsaan 
Malaysia Medical Centre (UKMMC). 
Demographic and clinical data of these 
patients were retrieved from the Record 
Department of UKMMC. A total of 98 
pregnant women were recruited for this 
study. They were uneventful pregnant 
women from 28 weeks to 32 weeks 
period of gestation attending Antenatal 
Clinic (n=62), or pregnant women with 
sensitizing events after 20 weeks of 
gestation (n=15) or pregnant women 
after spontaneous vaginal delivery. 
Women who were known to have 
Thalassaemia, were excluded. Three ml 
of maternal whole blood were collected 
into anticoagulated EDTA tube with 
prior consent. The samples were taken 
within two hours after spontaneous 
vaginal delivery, at any time during 
uneventful pregnancy between 28-32 
weeks or whenever patient admitted to 
hospital after post-sensitizing event. The 
samples were mixed thoroughly and 
checked for haemolysis or blood clots. 
They were then sent to the laboratory 
and processed within four hours after 
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collection. Haemolysed or clotted 
sample were rejected. The positive 
control sample was prepared in-house 
according to a documented protocol. 
The method described by the Members 
of the Scientific Subcommittee (SSC) of 
the Australian & New Zealand Society 
of Blood Transfusion (ANZSBT).
FLOW CYTOMETRY
In the flow cytometry method, the 
foetal red cells were identified using 
the monoclonal antibody against the 
HbF. The monoclonal anti-HbF used in 
this study was acquired commercially 
of Isotype IgG1, clone: WBAC HbF1 
(Chemicon, USA). It was designed for 
the detection and quantitation of HbF 
positive RBC arising in the circulation 
of mothers as a consequence of 
foetomaternal haemorrhage (FMH). The 
format in the study used the purified 
immunoglobulin conjugated to FITC. 
SILENIUS@FITC conjugated anti-HbF 
was supplied in phosphate buffered 
saline, pH 7.2, containing 0.2% BSA 
and 0.1% Sodium Azide. To maintain its 
applicability, the monoclonal antibody 
was stored at 2-8˚C in undiluted 
aliquots and is protected from sunlight. 
The methods for the cell suspension 
and reagent preparations were 
performed and prepared according 
to the manufacturer’s instruction. The 
reagents included the wash buffer, 
prefixation xolution, permeabilization 
solution and fixing solution. All the 
reagents were freshly prepared for 
every batch of test run. If not analyzed 
immediately, the cell suspension 
preparation can be stored at 4˚C in the 
dark for a maximum period of 24 hrs 
prior to analysis.
 The cell suspension were then 
analyzed on a FAC Scan flow cytometer. 
For each test, 50,000 events gating 
were collected on the RBC population. 
A linear forward scatter versus linear 
side scatter gate was selected. The 
vertical scale of fluorescence intensity 
histograms were adjusted so that the 
small foetal-HbF region, the adult ‘F’ 
cells and the adult negative cells could 
be visualized. The foetal-HbF region 
was set using the positive control and 
marked as ‘M’. The statistic analysis for 
the selected region was acquired and 
it showed the percentage foetal cells 
under the area marked as ‘M’ (Figure 1). 
The FMH was then calculated using the 
formula according to BCSH guidelines 
on the estimation of FMH (BCSH Blood 
Figure 1: A representative histogram plot of an estimated 1% artificial mixture showing a 
population of foetal cells in adult cells.
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Transfusion and General Haematology 
Task Force 1999);
FMH (ml)=
Area under the curve (M)  x  2400
100 - Area under the curve (M)
 To optimize the flow cytometer 
settings, two following standards were 
used; Mouse anti-IgG antibody was 
used and run in parallel with each 
sample tested to identify any non-
specific antibody binding. A positive 
control sample which contained 1% 
of HbF (10ml of cord blood added to 
990ml blood of a male person) was run 
in parallel with each batch of samples 
tested.
KELIHAUER’S TEST (ACID ELUTION 
TEST)
The thin blood films were prepared 
from the EDTA-anticoagulated samples 
from pregnant women. It was done 
by an experienced senior laboratory 
technician in accordance with the 
laboratories standard method and 
according to the local haematology 
laboratory standard operating 
procedure. The positive control slide 
was made from the smear of fresh cord 
blood to differentiate between adult 
and foetal cells. The control slides were 
performed with each batch of slides 
and treated in exactly the same way as 
the samples. Prior to the quantification 
of the FMH, screening of the control 
slides was performed to ensure that the 
staining were satisfactory. If not, the 
entire process was repeated and fresh 
new slides were obtained for the same 
sample.
 The quantification of FMH was 
carried out using a light microscope 
under 400 x magnification. An area 
of the film where cells were touching 
but not overlapping, was selected. Any 
foetal cell was counted in the area. The 
slide was moved across in sequence so 
that the next counting was continued 
for a minimum of 6000 adult cells 
ie. 15 fields examined under x400 
magnification, and the number of foetal 
cells were recorded. The FMH was 
calculated using the formula:
FMH (ml) = 
Number of Foetal cell (F)  x  2400
Number of Adult cell (A)
LINEARITY STUDY
Spiked samples were prepared by 
adding a known percentage of foetal 
cells to adult male cells (0.1%, 0.2%, 
0.3%, 0.4%, 0.5%, 1%, 5%). They were 
subjected to the FMH quantification 
by both methods (Figure 2-4). This 
test represented the linearity study 
experiment on both methods.
RESULTS
A total of 98 samples from pregnant 
women attended to Antenatal Clinic or 
admitted to UKMMC had quantification 
of FMH by flow cytometry with anti-
HbF and Kleihauer test. The age of 
the patients are between 20 and 42 
(median=30). None of them had any 
background medical problems. The 
following patients were included: 
women with uneventful pregnancy 
attending Antenatal Clinic (n=62), post 
spontaneous vaginal delivery (n=21) 
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and women admitted for antepartum 
haemorrhage or other sensitizing events 
(n=15).
LINEARITY STUDY
In the linearity experiment, the FMH 
estimated by the flow cytometer were 
plotted against the theoretical (known) 
estimated FMH (Figure 2). The results 
showed a correlation coefficient of 
r = 0.992. The FMH estimated by 
Kleihauer test plotted against the 
theoretical estimated FMH (Figure 3) 
showed a correlation coefficient of r 
= 0.87. The correlation study between 
the flow cytometer and the Kleihauer 
test for the FMH are shown in Figure 
4. All the results of % foetal cells and 
the FMH were shown to be higher in 
the Kleihauer test compared to the 
theoretical estimation and the flow 
cytometry. The results of the linearity 
study showed a good correlation 
between the flow cytometry and the 
kleihauer test in estimating the FMH 
with the correlation coefficient of r = 
0.896 respectively. All tests showed 
statistically significant results with p 
value less than 0.05 (p<0.05)
QUANTIFICATION OF FMH IN 
PREGNANT WOMEN
In this study, the results of the % foetal 
cells and the FMH from the patients’ 
samples showed fair correlation 
between flow cytometric method 
and Kleihauer test with correlation 
coefficient of r = 0.476 and r = 0.633 
(p<0.05), respectively (Figure 5 and 6). 
Overall, the results from the patients’ 
sample analysis of the FMH were shown 
to be higher by the flowcytometry 
in comparison to Kleihauer test. In 
70 cases (71.4%), the size of FMH 
quantitated by flow cytometry were 
Figure 2: Linearity study showing the 
correlation graph between the FMH estimated 
by the flow cytometry (y-axis) and the 
theoretically estmated FMH (x-axis).
Figure 3: Linearity study showing the 
correlation graph between the FMH estimated 
by the Kleihauer’s test (y-axis) and the 
theoretically estmated FMH (x-axis).
Figure 4: Linearity study showing the 
correlation graph between the FMH estimated 
by the flow cytometry (x-axis) and the 
Kleihauer’s test (y-axis).
r = 0.992 (p<0.05)
r = 0.87 (p<0.05)
r = 0.896 (p<0.05)
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higher than that estimated by Kleihauer 
test. Only 27 cases (27.6%) showed that 
the FMH quantification by Kleihauer 
test were higher compared to flow 
cytometry. One case showed no foetal 
cell detected by both methods (1%). 
Twenty eight out of all cases (28.6%) 
were detected positive for fetal cells by 
flow cytometry method (0.06 to 5.5%) 
but was negative by the Kleihauer test. 
None of the results which were detected 
positive by the Kleihauer test were 
negative by the flow cytometer. These 
results, suggested that flow cytometer 
was more sensitive than the Kleihauer 
test in detecting the foetal cell. There 
were 23 (23.7%) cases in which flow 
cytometry methods and the Kleihauer 
methods indicated a FMH of more than 
4ml and 45 (46.4%) cases indicated 
FMH of less than 4ml, thus giving the 
concordance rate of 70.1%. A further 
53 (54.6%) cases were associated with 
at least one method giving a result 
to suggest a bleed of more than 4ml. 
Twenty one (21.6%) cases showed FMH 
more than 4 ml when estimated by flow 
cytometer method but less than 4ml 
by Kleihauer test. Only 9 (9.3%) cases 
with FMH more than 4ml estimated by 
Kleihauer test were estimated less than 
4ml by the flow cytometer method. 
Analysis of all the results showed a fair 
correlation between the two methods 
for assessing the size of FMH and 
indicated that flow cytometry testing 
generally showed larger amount of 
FMH compared to Kleihauer test. 
However, flow cytometer seemed 
to be more sensitive in detecting the 
significant FMH of >4ml.
DISCUSSION
FMH estimation by flowcytometric 
technique can be done using 
monoclonal anti-HbF or monoclonal 
anti-D. The quantification by 
monoclonal anti-HbF has the advantage 
that it can be achieved irrespective of the 
blood groups of the mother and infants 
therefore enabling a flow cytometric 
method independently of the Rh 
antigens. Furthermore, the presence 
of maternal F cells did not interfere 
with the estimation since the intensity 
of staining is usually less than that of 
foetal cells. In the Kleihauer technique, 
there was no difference between an 
adult F cell and a true foetal cell. The 
Figure 5: The correlation graph between the 
% foetal cells estimated by flow cytometry 
(x-axis) and the Kleihauer test (y-axis).
Figure 6: The correlation graph between the 
estimated FMH by flow cytometry (x-axis) and 
Kleihauer test (y-axis). 
r = 0.476 (p<0.05)
r = 0.633 (p<0.05)
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addition of a calculated percentage 
of foetal cells from cord blood cells 
is used to help in identifying the cut-
off level. Nevertheless, it is known 
that only 95% of foetal cells stain with 
Kleihauer and a small percentage do 
not. Flowcytometric method on the 
other hand differentiates the adult F cell 
and a true foetal cells by virtue of their 
intensity in staining of the HbF.
 The current local policy for anti-D 
prophylaxis dosage is 500 IU (200 
mg) of anti-D which can theoretically 
neutralize 4 ml of foetal cells. Additional 
dosage of anti-D is given according to 
the FMH estimated by the Kleihauer 
test. It is very crucial to estimate FMH 
accurately because underestimation of 
the FMH can be dangerous as a lower 
dosage of anti-D would be given to 
such cases therefore, would not be 
sufficient to clear the foetal cells from 
the maternal circulation. On the other 
hand, overestimation of the FMH may 
result in giving a higher dosage of 
anti-D to such cases and would not be 
cost-effective. 
 In the present study, the linearity study 
results showed very good correlation 
between the known FMH and the 
results obtained by flowcytometric 
method and the Kleihauer’s test. There 
was also good correlation with the % 
foetal cells and FMH results obtained 
by flow cytometry and Kleihauer’s test. 
However, all the results of the % foetal 
cells and the FMH from the Kleihauer 
test showed higher values than the flow 
cytometer and the estimated theoretical 
% foetal cells. The results of flow 
cytometric method on the other hand 
showed, concordance results to the 
estimated theoretical values. Hence, 
we believe that the flow cytometer is a 
more accurate method to estimate the 
FMH than the Kleihauer test.
 Duckett & Constantine in (1997) had 
shown that a large inter-observer and 
inter-hospital variation in interpreting 
Kleihauer test slides where there was 
agreement in only 46% of cases. 
Janssen & Hoffmann (2002) suggested 
that the quantification of foetal red cells 
by flow cytometry with monoclonal 
anti-HbF to be highly accurate based 
on their linearity study.
 In our study, the results showed that 
there was a fair correlation between the 
% foetal cells and FMH results obtained 
by flow cytometry and Kleihauer test, r 
= 0.633 (p<0.05). Previous studies done 
by different authors in observing the 
correlation between the two methods 
in quantitating the FMH have shown 
that there is good correlation between 
the two methods with the majority 
obtained a correlation coefficient r > 
0.8 (p<0.05). Furthermore, our results, 
showed that in general, the flow 
cytometer gave higher results than the 
Kleihauer test. Other previous studies 
(Kennedy et al. 2003) on the other 
hand, showed that the Kleihauer test 
overestimates the FMH compared to 
the flow cytometry by using both anti-
HbF and anti-D. However, they also 
found that in samples containing <0.6% 
foetal cells, no significant difference in 
the detection of foetal cells between 
anti-HbF and anti-D (P = 0.11) but in 
samples containing >1% foetal cells, 
anti HbF significantly underestimates 
the percentage of foetal cells (P = 
0.0001). However, we were unable to 
determine from our findings whether 
the flow cytometry overestimate the 
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FMH or as opposed whether the 
Kleihauer test underestimates the FMH. 
The conclusion may be determined by 
the use of another third outcome or a 
‘gold standard’ for the estimation of 
FMH. This ‘gold standard’ has not been 
established yet. We also found in our 
study that some of the cases which were 
positive for foetal cells detected by flow 
cytometry were detected as negative 
by the Kleihauer test. None of the cases 
which were positive for the Kleihauer 
test were detected as negative by the 
flow cytometry method. These findings 
suggest that the flow cytometry is more 
sensitive in detecting the foetal cells. 
 The causes of the difference in the 
results from previous studies using 
flow cytometry have been suggested 
by some authors. The flow cytometry 
methodology with different reagents, 
the use of PE-conjugated anti-HbF 
instead of FITC-conjugated anti Hb-
F, the use of PBS azide for washes 
and resuspension instead of PBS with 
bovine serum albumin, and a longer 
incubation time with the Triton-X 
reagent (8 mins instead of 3-5 mins). 
Another factor to be considered is the 
contamination by the white cell which 
can exhibit autofluorescence and may 
cause an overestimation of the FMH as 
demonstrated by Janssen & Hoffman 
(2002). Several authors have suggested 
the use of monoclonal anti-CD45 or 
propidium iodide, a fluorescent dye 
specific for DNA to check for the 
contamination. Previous studies have 
mentioned various differences in the 
methodology that may cause the 
different results by flow cytometry. 
Johnson et al. (1995) and Llyod-Evans et 
al. (1999) have shown that monoclonal 
anti-D is more accurate compared 
with anti-HbF in detecting foetal cells 
and quantification of FMH. The use 
of phycoerythrin (PE) or fluorescein 
(FITC) as fluorescence dye may also 
cause different results. Few authors 
have suggested that the use of PBS 
azide rather than PBS with bovine 
serum albumin and longer incubation 
with Triton-X could contribute to the 
difference in the results. However, so 
far, there has been no individual study 
to look specifically into this matter. 
White cell autofluorescence can give 
false positive results. The use of double 
labeling with phycoerythrin conjugated 
anti-glycophorin A monoclonal 
antibody rather than single labeling with 
either anti-HbF or anti-D can improve 
the accuracy of FMH quantification 
(Llyod-Evans et al. 1999). The use of 
monoclonal anti-CD45 and propidium 
iodide to check for contamination 
of nucleated cells have also been 
suggested and proved to improve the 
accuracy (Janssen & Hoffman 2002).
 In our study, we used single labeling 
technique with FITC conjugated anti 
Hb-F, PBS azide during washing 
procedure and adopted  the 3-5 
minutes incubation time with 
Triton-X (permeabilizing solution) as 
recommended by the manufacturer. 
We did not employ double labeling 
to exclude white cell contamination. 
These different in the methodology 
may have contributed to our findings. 
We therefore, recommend to use a 
double labeling rather than single 
labeling of the monoclonal antibody 
in order to improve the accuracy in the 
quantification of FMH. We also would 
like to further evaluate and compare 
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the use of monoclonal anti-HbF and 
monoclonal anti-D in the evaluation of 
FMH. 
CONCLUSION
In conclusion, our study showed a 
fair correlation between the FMH 
quantification by flow cytometric 
method and the Kleihauer test. In 
addition, the linearity study showed 
that the flow cytometer is very accurate 
in detecting the foetal cells thus 
estimating the FMH. 
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